Antioxidant and cytotoxic effects of Chrozophora rottleri fruit ethanol extract
Abstract
Liver cancer, particularly hepatocellular carcinoma (HCC), occurs from liver cell abnormalities, influenced by factors such viral hepatitis, obesity toxins and drugs. Non-Alcoholic Fatty Liver Disease (NAFLD) exacerbates liver disorders globally, marked by fat accumulation, whereas liver fibrosis raises cancer risk in NAFLD and Alcohol-Induced Liver Disease (ALD). Herbal medicine gains attraction for liver health, offering hepatoprotective benefits. Medicinal plant metabolites, particularly polyphenols, display antioxidative effects, possibly suppressing cancer cell development. This work focuses on evaluating the possible antioxidant and cytotoxic effects of Chrozophora rottleri fruit ethanol extract (CRFEE) using in-vitro experiments. The antioxidant capacity of CRFEE was examined by hydroxyl radical and nitric oxide scavenging experiments. CRFEE revealed considerable scavenging efficacy against both radicals, suppressing hydroxyl radicals by 48.25% with an IC50 of 35.08±1.62 μg/ml and nitric oxide by 49.35% with an IC50 of 307.44±2.28 μg/ml. Notably, CRFEE displayed better antioxidant efficiency compared to the standard antioxidant, butylated hydroxyl toluene (BHT), in neutralizing hydroxyl radicals. Additionally, the in-vitro cytotoxicity of Chrozophora rottleri fruit ethanol extract (CRFEE) was examined using the MTT test on HepG-2 cell line cultures. CRFEE had strong detrimental effects on HepG-2 cells, with higher dosages resulting to a major loss in cell viability. The IC50 value for CRFEE was determined 63±0.08μg/mL, suggesting its efficacy in reducing HepG-2 cell proliferation. The results demonstrate substantial antioxidant activity and cytotoxic effects against liver cancer cells (HepG-2 cell line). The bioactive chemicals contained in CRFEE show potential for future pharmaceutical applications, underscoring the relevance of natural-based research in cancer therapy and the necessity for further exploration in vivo.
Keywords:
Chrozophora rottleri, liver cancer, Antioxidants, MTT test , HepG-2 cell lineDOI
https://doi.org/10.25004/IJPSDR.2024.160405References
Chidambaranathan-Reghupaty S, Fisher PB, Sarkar D. Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification. Advances in Cancer Research. 2021 Jan 1; 149:1-61. Available from: https://doi.org/10.1016/bs.acr.2020.10.001
Tariq MU, Din NU, Abdul-Ghafar J, Park YK. The many faces of solitary fibrous tumor; diversity of histological features, differential diagnosis and role of molecular studies and surrogate markers in avoiding misdiagnosis and predicting the behavior. Diagnostic Pathology. 2021 Dec; 16:1-4. Available from: https://doi.org/10.1186/s13000-021-01095-2
Devar bhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. Journal of Hepatology. 2023 Aug 1; 79(2):516-37. Available from: https://doi.org/10.1016/j.jhep.2023.03.017
Wu XN, Xue F, Zhang N, Zhang W, Hou JJ, Lv Y, Xiang JX, Zhang XF. Global burden of liver cirrhosis and other chronic liver diseases caused by specific etiologies from 1990 to 2019. BMC Public Health. 2024 Feb 3; 24(1):363. Available from: https://doi.org/10.1186/s12889-024-17948-6
Mitra S, De A, Chowdhury A. Epidemiology of non-alcoholic and alcoholic fatty liver diseases. Translational Gastroenterology and Hepatology. 2020; 5. Available from: https://doi.org/10.21037/tgh.2019.09.08
Koulouris A, Tsagkaris C, Spyrou V, Pappa E, Troullinou A, Nikolaou M. Hepatocellular carcinoma: an overview of the changing landscape of treatment options. Journal of Hepatocellular Carcinoma. 2021 May 13:387-401. Available from: https://doi.org/10.2147/jhc.s300182
Debela DT, Muzazu SG, Heraro KD, Ndalama MT, Mesele BW, Haile DC, Kitui SK, Manyazewal T. New approaches and procedures for cancer treatment: Current perspectives. SAGE Open Medicine. 2021 Aug; 9:20503121211034366. Available from: https://doi.org/10.1177/20503121211034366
Addissouky TA, Sayed IE, Ali MM, Wang Y, Baz AE, Khalil AA, Elarabany N. Latest advances in hepatocellular carcinoma management and prevention through advanced technologies. Egyptian Liver Journal. 2024 Jan 2; 14(1):2. Available from: https://doi.org/10.1186/s43066-023-00306-3
Zhang Z, Liu X, Chen D, Yu J. Radiotherapy combined with immunotherapy: the dawn of cancer treatment. Signal Transduction and Targeted Therapy. 2022 Jul 29; 7(1):258. Available from: https://doi.org/10.1038/s41392-022-01102-y
Seeff LB, Lindsay KL, Bacon BR, Kresina TF, Hoofnagle JH. Complementary and alternative medicine in chronic liver disease. Hepatology. 2001 Sep 1; 34(3):595-603. https://doi.org/10.1053/jhep.2001.27445
Ugwu CE, Suru SM. Medicinal plants with hepatoprotective potentials against carbon tetrachloride-induced toxicity: a review. Egyptian Liver Journal. 2021 Dec; 11:1-26. Available from: https://doi.org/10.1002/med.20115
kim DB, Lee DK, Cheon C, Ribeiro RI, Kim B. Natural products for liver cancer treatment: From traditional medicine to modern drug discovery. Nutrients. 2022 Oct 12; 14(20):4252. Available from: https://doi.org/10.3390/nu14204252
Tauro S, Dhokchawle B, Mohite P, Nahar D, Nadar S, Coutinho E. Natural anticancer agents: their therapeutic potential, challenges and promising outcomes. Current Medicinal Chemistry. 2024 Feb 1; 31(7):848-70. Available from: https://doi.org/10.2174/0929867330666230502113150
Machado IF, Miranda RG, Dorta DJ, Rolo AP, Palmeira CM. Targeting oxidative stress with polyphenols to fight liver diseases. Antioxidants. 2023 Jun 3; 12(6):1212. Available from: https://doi.org/10.3390/antiox12061212
Roy Z, Bansal R, Siddiqui L, Chaudhary N. Understanding the role of free radicals and antioxidant enzymes in human diseases. Current Pharmaceutical Biotechnology. 2023 Aug 1; 24(10):1265-76.
Rizzo M, Colletti A, Penson PE, Katsiki N, Mikhailidis DP, Toth PP, Gouni-Berthold I, Mancini J, Marais D, Moriarty P, Ruscica M. Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD). Pharmacological Research. 2023 Mar 1; 189:106679. Available from: https://doi.org/10.3390/nu10091153
Zarzour RH, Ahmad M, Asmawi MZ, Kaur G, Saeed MA, Al-Mansoub MA, Saghir SA, Usman NS, Al-Dulaimi DW, Yam MF. Phyllanthus niruri standardized extract alleviates the progression of non-alcoholic fatty liver disease and decreases atherosclerotic risk in Sprague–Dawley rats. Nutrients. 2017 Jul 18; 9(7):766. Available from: https://doi.org/10.3390/nu9070766
Shetty SN, Mengi S, Vaidya R, Vaidya AD. A study of standardized extracts of PicrorhizakurroaRoyle ex Benth in experimental nonalcoholic fatty liver disease. Journal of Ayurveda and Integrative Medicine. 2010 Jul; 1(3):203. Available from: https://doi.org/10.4103/0975-9476.72622
Saadati S, Sadeghi A, Mansour A, Yari Z, Poustchi H, Hedayati M, Hatami B, Hekmatdoost A. Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial. BMC Gastroenterology. 2019 Dec; 19:1-6. Available from: https://doi.org/10.1186/s12876-019-1055-4
Vlizlo V, Prystupa O, Slivinska L, Gutyj B, Maksymovych I, Shcherbatyy A, Lychuk M, Partyka U, Chernushkin B, Rusyn V, Leno M. Treatment of animals with fatty liver disease using a drug based on the seeds of Silybum marianum. Regulatory Mechanisms in Biosystems. 2023 Aug 23; 14(3):424-31. Available from: https://doi.org/10.15421/10.15421/022362
Kavitha G, Pallavi M, Chandrashekar S, Dharmashekar C, Bhargav S, Prasad KS, Chandan S, Ashiwini P. Evaluation of antimutagenic potential of Chrozophora rottleri against ems induced mutagenicity in mice. International Journal of Pharma and Bio Sciences. 2022 Jan 27; 13(1):125–33. Available from: https://doi.org/10.22376/ijpbs.2022.13.1.b125-133
Keerthana P, Babu K, Austin A. Pharmacognostic and phytochemical evaluation of Chrozophora rottleri (Geiseler) A. Juss. Ex Spreng. Journal of Pharmacognosy and Phytochemistry. 2020; 9(3):2066-72.
Narmadaa T, Devi RR, Sivaraman S, Babu HS. Phytochemical screening of the common weed Chrozophora rottleri to explore the antioxidant property. Research Journal of Pharmaceutical Biological and Chemical Sciences. 2012; 593-596.
Bhavy S, Sudhir Chandra Varma, Kumar B. Phytochemical Evaluation of Chrozophora rottleri (Geiseler) A. Juss. Ex Spreng. International journal of Current Microbiology and Applied Sciences. 2018 Aug 10; 7(08):4554–85. Available from: https://doi.org/10.20546/ijcmas.2018.708.482
Talluri MR, Rao BG, Rao YV. Anti-Inflammatory Activity of Chrozophora rottleri extracts on carrageenan-induced rat paw edema. International Journal of Pharmacology, Phytochemistry and Ethnomedicine. 2016; 3:20-6. Available from: https://doi.org/10.18052/www.scipress.com/ijppe.3.20
Kavitha GC, Riaz Mahmood, Pallavi M. Estimation of total phenolics, flavonoid and In vitro antioxidant activity of Chrozophora rottleri. European Journal of Biomedical and Pharmaceutical Sciences. 2017.
Hajji Nabih M, Boulika H, El Hajam M, Alghonaim MI, Kandri NI, Alsalamah SA, Boufahja F. Successive solvent extraction, characterization and antioxidant activities of cardoon waste (Leaves and Stems) extracts: comparative study. Molecules. 2023 Jan 23; 28(3):1129. Available from: https://doi.org/10.3390/molecules28031129.
Zhou J, Yang Q, Zhu X, Lin T, Hao D, Xu J. Antioxidant activities of Clerodendrum cyrtophyllum Turcz leaf extracts and their major components. PlOS One. 2020 Jun 23; 15(6):0234435. Available from: https://doi.org/10.1371/journal.pone.0234435
Boora F, Chirisa E, Mukanganyama S. Evaluation of nitrite radical scavenging properties of selected Zimbabwean plant extracts and their phytoconstituents. Journal of Food Processing. 2014; 2014:1-7. Available from: https://doi.org/10.1155/2014/918018
Morgan DM. Tetrazolium (MTT) assay for cellular viability and activity. Polyamine Protocols. 1998:179-84. Available from: https://doi.org/10.1385/0-89603-448-8:179
Dehelean CA, Marcovici I, Soica C, Mioc M, Coricovac D, Iurciuc S, Cretu OM, Pinzaru I. Plant-derived anticancer compounds as new perspectives in drug discovery and alternative therapy. Molecules. 2021 Feb 19; 26(4):1109. Available from: https://doi.org/10.3390/molecules26041109
Kudamba A, Kasolo JN, Bbosa GS, Lugaajju A, Wabinga H, Kafeero HM, Ssenku JE, Alemu SO, Walusansa A, Niyonzima N, Muwonge H. Review of herbal medicinal plants used in the management of cancers in the east Africa region from 2019 to 2023. Integrative Cancer Therapies. 2024 Mar; 23:1534. Available from: https://doi.org/10.1177/15347354241235583
GAgyare C, Spiegler V, Asase A, Scholz M, Hempel G, Hensel A. An ethno pharmacological survey of medicinal plants traditionally used for cancer treatment in the Ashanti region, Ghana. Journal of Ethno pharmacology. 2018 Feb 1;212:137–52. Available from: https://doi.org/10.1016/j.jep.2017.10.019
Gezici S, Şekeroğlu N. Current perspectives in the application of medicinal plants against cancer: novel therapeutic agents. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents). 2019 Jan 1; 19(1):101-11.Available from: https://doi.org/10.2174/1871520619666181224121004
Dhyani P, Quispe C, Sharma E, Bahukhandi A, Sati P, Attri DC, Szopa A, Sharifi-Rad J, Docea AO, Mardare I, Calina D. Anticancer potential of alkaloids: a key emphasis to colchicine, vinblastine, vincristine, vindesine, vinorelbine and vincamine. Cancer Cell International. 2022 Jun 2; 22(1):206. Available from: https://doi.org/10.1186/s12935-022-02624-9
Jimenez Gonzalez V, Kowalczyk T, Piekarski J, Szemraj J, Rijo P, Sitarek P. Nature’s green potential: anticancer properties of plants of the Euphorbiaceae family. Cancers. 2023 Dec 25; 16(1):114. Available from: https://doi.org/10.3390/cancers16010114
Oke-Altuntas F, Ipekcioglu S, SahinYaglioglu A, Behcet L, Demirtas I. Phytochemical analysis, anti proliferative and antioxidant activities of Chrozophora tinctoria: a natural dye plant. Pharmaceutical biology. 2017 Jan 1; 55(1):966-73. Available from: https://doi.org/10.1080/13880209.2016.1277767
Published
Abstract Display: 502 
PDF Downloads: 508 How to Cite
Issue
Section
Copyright (c) 2024 Y R Nagesh, Riaz Mahmood
This work is licensed under a Creative Commons Attribution 4.0 International License.
